Crossmark

Malignant Pleural Mesothelioma: Is Tailoring the Second-Line Therapy Really “Raising the Bar?”

Crossref DOI link: https://doi.org/10.1007/s11864-019-0616-7

Published Online: 2019-02-21

Published Print: 2019-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Di Noia, Vincenzo

Vita, Emanuele

Ferrara, Miriam

Strippoli, Antonia

Basso, Michele

Schinzari, Giovanni

Cassano, Alessandra

Bria, Emilio

Barone, Carlo

D’Argento, Ettore
License Information

Text and Data Mining valid from 2019-02-21
More Information

Article History

First Online: 21 February 2019

Compliance with Ethical Standards

:

: Vincenzo Di Noia, Emanuele Vita, Miriam Ferrara, Antonia Strippoli, Michele Basso, Giovanni Schinzari, Alessandra Cassano, Emilio Bria, Carlo Barone, and Ettore D’Argento declare they have no conflict of interest.

: This article does not contain any studies with human or animal subjects performed by any of the authors.